Heat Biologics Inc. (HTBX) Declined -7.29% or -0.21 To Price $2.67 On Thursday


Heat Biologics Inc. (HTBX) declined -7.29% or -0.21 to $2.67. It is around 142857 shares traded, which is 39.59% compare to the average total volume 360802. The market cap of HTBX is $955564. The year to date change is -26.15%. The 52 week price range is from $2.6 to $12.5. Price of HTBX have changed -13.25% during last week. It have changed -28.91% over last month, -52.79% over last 3 months, -43.53% over last 6 months and -68.71% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HTBX is 3.80. It is 42.32% above current price. The 200-day Moving Averages for HTBX is 5.55. It is 107.87% above current price. The 52-week High is 12.5. It is 368.16% from the current price. The 52-week Low is 2.6. It is -2.62% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of HTBX is 1.83 on 2018-01-12. Short % to float is 27.51%. There are some statistics of HTBX. It is has market cap $955564. The share outstanding is 357889. The average volume is 360802. The revenue is 1.03M. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HTBX is -158.93%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HTBX is -97.66%.


Tags:

Share this post